tradingkey.logo
tradingkey.logo
Search

Purple Biotech Reports Final Data From Phase 2 Study Of CM24 In Pancreatic Cancer Patients At AACR 2025 Annual Meeting

ReutersApr 30, 2025 11:14 AM
facebooktwitterlinkedin
View all comments0

- Purple Biotech Ltd PPBT.TA:

  • PURPLE BIOTECH REPORTS FINAL DATA FROM PHASE 2 STUDY OF CM24 IN PANCREATIC CANCER PATIENTS AT AACR 2025 ANNUAL MEETING: IMPROVED OUTCOMES AND SIGNIFICANT EFFICACY IN BIOMARKER-ENRICHED SUBGROUPS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI